Menu

Experience

Marina Remennik

    • Rani Therapeutics – $73 Million IPO 


    • Dynavax Technologies – $200 Million Convertible Notes Offering 


    • TiVo and Xperi to Combine in $3 Billion All-Stock Merger 


    • Sonim Technologies – $39 Million IPO 


    • Rovi Receives Antitrust Clearance for TiVo Acquisition 


    • Rovi Acquires TiVo for $1.1 Billion 


    • Rovi Corporation Completes $345 Million Convertible Note Offering 


    • Revance $110 Million Initial Public Offering 


    • Depomed $240 Million Diabetes Drug Sale to PDL BioPharma 


    • AcelRx Pharmaceuticals in Public Offering